中国仓鼠卵巢细胞
细胞培养
细胞生长
生物
天冬酰胺
生化工程
谷氨酰胺
生物制药
化学定义介质
生物信息学
生物技术
生物化学
计算生物学
氨基酸
工程类
体外
遗传学
基因
作者
Seo‐Young Park,Dong‐Hyuk Choi,Jinsung Song,Uiseon Park,Hyeran Cho,Bee Hak Hong,Yaron Silberberg,Dong‐Yup Lee
标识
DOI:10.1002/biot.202300126
摘要
Designing and selecting cell culture media along with their feeding are a key strategy to maximize culture performance in biopharmaceutical processes. However, the sensitivity of mammalian cells to their culture environment necessitates specific nutritional requirements for their growth and the production of high-quality proteins such as antibodies, depending on the cell lines and operational conditions employed. In this regard, previously we developed a data-driven and in-silico model-guided systematic framework to investigate the effect of growth media on Chinese hamster ovary (CHO) cell culture performance, allowing us to design and reformulate basal media. To expand our exploration for media development research, we evaluated two chemically defined feed media, A and B, using a monoclonal antibody-producing CHO-K1 cell line in ambr15 bioreactor runs. We observed a significant impact of the feed media on various aspects of cell culture, including growth, longevity, viability, productivity, and the production of toxic metabolites. Specifically, the concentrated feed A was inadequate in sustaining prolonged cell culture and achieving high titers when compared to feed B. Within our framework, we systematically investigated the major metabolic bottlenecks in the tricarboxylic acid cycle and relevant amino acid transferase reactions. This analysis identified target components that play a crucial role in alleviating bottlenecks and designing highly productive cell cultures, specifically the addition of glutamate to feed A and asparagine to feed B. Based on our findings, we reformulated the feeds by adjusting the amounts of the targeted amino acids and successfully validated the effectiveness of the strategy in promoting cell growth, life span, and/or titer.
科研通智能强力驱动
Strongly Powered by AbleSci AI